ANGIOBLAST SYSTEMS

Welcome to the Brand page for “ANGIOBLAST SYSTEMS”, which is offered here for Pharmaceutical preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications; veterinary preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications; biotechnology preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications; medical preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications; diagnostic preparations and reagents for medical purposes; culture fluids, cultures of micro-organisms for medical purposes; human allograft tissue; animal allograft tissue; human tissue and animal tissue for transplantation or implantation, medical and surgical purposes; human cells including stem cells, animal cells including stem cells for medical or clinical use; pharmaceutical preparations for the treatment, reconstruction and repair of tissue;color is not claimed as a feature of the mark.;angioblast systems;scientific, research, clinical research, development, advisory and consultancy services in relation to t-cell production, t-cell immunotherapy, cell culture devices, tissue engineering for cellular applications for humans and animals, stem cell banking, tissue banking, drug discovery, vaccine screening, cell culture methods, cell expansion technology including stem cell expansion technology, cellular therapies including stem cell therapies and cellular transplants;.

Its status is currently believed to be active. Its class is unavailable. “ANGIOBLAST SYSTEMS” is believed to be currently owned by “Mesoblast Inc”.